Resecciones mayores por enfermedades malignas torácicas

1. The Society of Thoracic Surgeons. STS national database 2013. Available at:http://www.sts.org/sections/stsnationaldatabase. Accessed June 14, 2013.
2. S.F. Khuri, J. Daley, W. Henderson, et al. The Department of Veterans Affairs’ NSQIP: the first national, validated, outcome-based, risk-adjusted, and peer-controlled program for the measurement and enhancement of the quality of surgical care. Ann Surg, 228 (1998), pp. 491–507
3. National Research Council Delivering high-quality cancer care: charting a new course for a system in crisis. The National Academies Press, Washington, DC (2013)
4. A.S. Bryant, K. Rudemiller, R.J. Cerfolio. The 30- versus 90-day operative mortality after pulmonary resection. Ann Thorac Surg, 89 (2010), pp. 1717–1723
5. H.A. Powell, L.J. Tata, D.R. Baldwin, et al. Early mortality after surgical resection for lung cancer: an analysis of the English National Lung cancer audit. Thorax, 68 (2013), pp. 826–834
6. R.A. Damhuis, B.P. Winhoven, P.W. Plaisier, et al. Comparison of 30-day, 90-day and in-hospital postoperative mortality for eight different cancer types. Br J Surg, 99 (2012), pp. 1149–1154
7. T. Crabtree, V. Puri, R. Timmerman, et al. Treatment of stage I lung cancer in high-risk and inoperable patients: comparison of prospective clinical trials using stereotactic body radiotherapy (RTOG 0236), sublobar resection (ACOSOG Z4032), and radiofrequency ablation (ACOSOG Z4033). J Thorac Cardiovasc Surg, 145 (2013), pp. 692–699
8. N.E. Verstegen, J.W. Oosterhuis, D.A. Palma, et al. Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis. Ann Oncol, 24 (2013), pp. 1543–1548
9. M.L. Johnson, H.S. Gordon, N.J. Petersen, et al. Effect of definition of mortality on hospital profiles. Med Care, 40 (2002), pp. 7–16